Online citations, reference lists, and bibliographies.

Poorer Survival Of Elderly Patients With Ovarian Cancer: A Population-based Study.

P. Petignat, G. Fioretta, H. Verkooijen, A. Vlastos, E. Rapiti, C. Bouchardy, G. Vlastos
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE To compare ovarian cancer survival in elderly and young patients. MATERIAL AND METHODS Using the Geneva Cancer Registry, we identify women diagnosed with primary ovarian cancer between 1980 and 1998. We compared tumors characteristics, treatment patterns of young patients (70 years) by logistic regression. To evaluate the effect of age on prognosis, we compared disease specific survival by Cox proportional hazard analysis, taking into account other prognostic factors. RESULTS This study included 285 patient aged 70 years and 451
This paper references
10.1006/gyno.1993.1007
Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer.
T. Hoegberg (1993)
Surgical treatment of the elderly patient with gynecologic cancer.
C. Kirschner (1990)
10.1016/S0029-7844(03)00123-6
Survival and Prognostic Factors in Patients With Ovarian Cancer
S. Tingulstad (2003)
10.32388/1bjeus
International Classification of Diseases for Oncology
Constance L. Percy (1990)
Ovarian cancer in elderly women.
N. Lambrou (2003)
10.1006/GYNO.2001.6328
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
D. Chi (2001)
10.1007/978-3-642-85849-9
Cancer incidence in five continents.
Freddie Ian Bray (1976)
10.1016/J.AJOG.2004.01.078
Morbidity of cytoreductive surgery in the elderly.
J. Wright (2004)
10.1006/GYNO.2001.6460
A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
M. Carney (2002)
10.1016/S0002-9378(03)00940-2
Morbidity and mortality rates of elective gynecologic surgery in the elderly woman.
M. Toglia (2003)
10.1200/JCO.2003.08.065
Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
R. Cress (2003)
10.1002/CNCR.2820710220
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study
D. Alberts (1993)
10.1002/CNCR.2820710222
Epithelial ovarian cancer in the elderly: The memorial sloan‐kettering cancer center experience
M. Markman (1993)
10.1006/gyno.1993.1091
Treatment of advanced ovarian carcinoma in the elderly.
D. Marchetti (1993)
10.1002/CNCR.2820710218
Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience
T. Thigpen (1993)
10.1002/CNCR.2820710216
Age does not influence taxol dose intensity in recurrent carcinoma of the ovary
A. Bicher (1993)
10.1006/GYNO.1998.5337
Management of ovarian cancer in patients older than 80 years of Age.
N. Cloven (1999)



This paper is referenced by
10.1016/j.ejso.2012.08.003
Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management?
Francesco Fanfani (2012)
Analyse descriptive du profil des patients de plus de 75 ans admis en Court Séjour Gériatrique porteurs d'une néoplasie
Charlotte Bucciero (2018)
10.1111/j.1525-1438.2007.00908.x
Gene expression in epithelial ovarian cancer: a study of intratumor heterogeneity
K. Jochumsen (2006)
10.1007/s11864-009-0093-5
Chemotherapy for Ovarian Cancer in the Older Adult
Christopher B Steer (2009)
10.1007/978-3-319-32110-3_9
Ovarian Cancer in the Elderly
Claire Falandry (2017)
10.1007/978-3-319-43365-3_7
Cancer, Ageing and Immunosenescence
Nora Manoukian Forones (2017)
10.1111/J.1525-1438.2007.00912.X
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience
D. Pectasides (2006)
10.1016/j.ygyno.2016.11.006
Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.
R. Sorio (2017)
10.1097/IGC.0b013e318234f8d5
Management of the Elderly Patient With Gynecologic Cancer: Report of the 2011 Workshop in Geriatric Gynecologic Oncology
D. Suh (2012)
10.7150/jca.29611
Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging
Hye Sook Chon (2019)
10.1016/j.jogc.2020.04.014
Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer.
S. Piedimonte (2020)
Prospective study of symptoms of ovarian cancer in postmenopausal women
P. L. Allen (2010)
10.1007/978-1-4471-4605-6_14
Management of Recurrent Ovarian Cancer in Older Women
Nuria Romero (2013)
10.1007/s11864-009-0114-4
Ovarian Cancer Cytoreductive Surgery in the Elderly
G. Gardner (2009)
10.4321/S1130-01082008001000005
Carcinoma hepatocelular en el anciano: características clínicas, análisis de supervivencia y factores pronósticos en una cohorte de pacientes españoles mayores de 75 años
M. Fernández-Ruiz (2008)
10.1007/s00432-020-03168-z
Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data
Mayumi Kobayashi Kato (2020)
10.1089/GYN.2009.0036
Racial Differences in Treatment Modalities Among Female Residents of Florida Diagnosed with Epithelial Ovarian Cancer
V. L. Williams (2010)
10.3802/jgo.2010.21.4.209
Major clinical research advances in gynecologic cancer in 2010.
D. Suh (2010)
10.1186/s40661-017-0040-2
Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
R. Chekerov (2017)
10.1186/s12885-015-1947-9
Under-treatment of elderly patients with ovarian cancer: a population based study
Elisabeth Fourcadier (2015)
Prognosis for ovarian cancer in Denmark 1980-2005: Studies of use of hospital discharge data to monitor and study prognosis and impact of comorbidity and venous thromboembolism on survival PhD thesis
M. Tetsche (2007)
10.1016/j.ogc.2012.02.003
Trends in gynecologic cancer care in North America.
C. Reade (2012)
10.14744/ejmo.2017.43531
Assessment of Prognostic Factors in Epithelial Ovarian Cancer
Yýlmaz Onal (2017)
10.1053/j.seminoncol.2008.08.007
Ovarian cancer in older women.
W. Tew (2008)
10.1634/theoncologist.2012-0155
Doublet chemotherapy in the elderly patient with ovarian cancer.
M. Teo (2012)
10.1007/2-287-30921-7_7
Facteurs pronostiques des tumeurs épithéliales malignes de l’ovaire
R. Largillier (2006)
10.1007/978-1-4471-4605-6_3
Geriatric Issues in Ovarian Cancer
Miriam B. Rodin (2013)
10.1007/s10269-007-0781-3
Spécificité du cancer de l’ovaire chez la personne âgée
C. Falandry (2007)
10.31557/APJCP.2019.20.2.437
Net Survival of Elderly Patients with Gynecological Cancer Aged Over 75 Years in 2006-2008
Shusaku Inoue (2019)
10.1016/j.ejogrb.2014.10.001
Borderline ovarian tumor in women aged ≥ 65 years: impact on recurrence and survival.
T. Song (2015)
10.1111/J.1525-1438.2006.00580.X
Long‐term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures
A. Tentes (2006)
10.1111/J.1525-1438.2007.00836.X
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients
T. Susini (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar